Recent studies showed that TIM-3 and galectin-9 interaction was involved in the immune escape of several malignancies such as acute myeloid leukemia (AML) and non-small cell lung cancer (41, 42). Here, HAVCR2 is linked to non-small cell lung carcinoma.